Related Experiment Video

Updated: Jun 5, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

870

Non‑coding RNA‑mediated epigenetic modification of ferroptosis in non‑small cell lung cancer (Review)

Yumin Wang1, Joshua S Fleishman2, Yulin Li1

  • 1Department of Respiratory and Critical Care Medicine, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine, Beijing 100049, P.R. China.

International Journal of Oncology
|December 13, 2024
PubMed

Insights

Ferroptosis, a cell death form, inhibits cancer. Non-coding RNAs epigenetically regulate ferroptosis vulnerability in non-small-cell lung cancer (NSCLC), offering new therapeutic strategies targeting the ncRNA-ferroptosis axis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Ferroptosis is a regulated cell death pathway crucial for tumor suppression.
  • Non-coding RNAs (ncRNAs) are increasingly recognized for their roles in cancer epigenetics.
  • Non-small-cell lung cancer (NSCLC) presents significant therapeutic challenges.

Purpose of the Study:

  • To review the molecular mechanisms of ferroptosis.
  • To elucidate the role of epigenetic modifications, particularly ncRNAs, in regulating ferroptosis in NSCLC.
  • To highlight the potential of the ncRNA-ferroptosis axis as a therapeutic strategy for NSCLC.

Main Methods:

  • Literature review of ferroptosis mechanisms.
  • Analysis of epigenetic regulation by ncRNAs in cancer.
  • Synthesis of current research on ferroptosis and ncRNAs in NSCLC.

Main Results:

  • Ferroptosis signaling pathways offer novel therapeutic avenues for lung cancer.
  • ncRNA-mediated epigenetic modifications influence cancer cell sensitivity to ferroptosis.
  • Specific ncRNA mechanisms modulating ferroptosis in NSCLC have been identified.

Conclusions:

  • Understanding ncRNA-mediated epigenetic regulation of ferroptosis is key for NSCLC treatment.
  • Targeting the ncRNA-ferroptosis axis presents a promising novel therapeutic strategy for NSCLC.
Keywords:
ferroptosislung cancernon‑coding RNAnon‑small cell lung cancer

More Related Videos

Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells11:11

Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells

Published on: April 25, 2018

8.0K
Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts09:21

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Published on: February 23, 2024

829

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.3K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.7K
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
141.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K